Thus, pancreatic PPARα signaling appears to besignificant “in vivo” and, when PPARα is activated due toelevated fatty acid levels, as in obesity, it may contribute toglucose intolerance and β-cell dysfunction. Here, PPARA is linked to obesity due to melanocortin 4 receptor deficiency.